SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 10, 1998
BOSTON SCIENTIFIC CORPORATION
-----------------------------
(Exact name of registrant as specified in charter)
DELAWARE 1-11083 04-2695240
- ------------------ ----------- ------------------
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
ONE BOSTON SCIENTIFIC PLACE, NATICK, MASSACHUSETTS 01760-1537
-------------------------------------------------- ----------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (508) 650-8000
ITEM 5. OTHER EVENTS
On October 6, 1997, Boston Scientific Corporation (the "Company") filed a
Registration Statement on Form S-3 with the Securities and Exchange Commission
(the "Commission") relating to the public offering pursuant to Rule 415 under
the Securities Act of 1933, as amended, of up to an aggregate of $500,000,000 in
securities of the Company. On October 9, 1997, the Commission declared the
Registration Statement effective (File No. 333-37255).
On February 27, 1998, the Company filed a Preliminary Prospectus Supplement
to the Prospectus forming a part of the Registration Statement pursuant to Rule
424(b) under the Securities Act relating to the issuance and sale of an
aggregate of $500,000,000 principal amount of unsecured notes, subject to final
terms and pricing.
On March 5, 1998, the Company filed a Final Prospectus Supplement pursuant
to Rule 424(b) under the Securities Act relating to the issuance and sale of
6.625% Notes due March 15, 2005 in the aggregate principal amount of
$500,000,000. On March 10, 1998, the Company closed this public debt offering.
A copy of the Underwriting Agreement, Terms Agreement and Notes are
attached as exhibits hereto and are incorporated herein and in the Registration
Statement by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
Exhibit Number Description
- -------------- -----------
1.1 Underwriting Agreement dated March 5, 1998 among Boston
Scientific Corporation and Lehman Brothers Inc. and Bear,
Stearns & Co., Inc., as Representatives of the several
Underwriters
1.2 Terms Agreement dated March 5, 1998 among Boston Scientific
Corporation and Lehman Brothers Inc. and Bear, Stearns & Co.,
Inc., as Representatives of the several Underwriters
4.1 6 5/8% Note due March 15, 2005 in the principal amount of
$200,000,000
4.2 6 5/8% Note due March 15, 2005 in the principal amount of
$200,000,000
4.3 6 5/8% Note due March 15, 2005 in the principal amount of
$100,000,000
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: March 30, 1998 By: /s/ Lawrence C. Best
----------------------
Lawrence C. Best
Senior Vice President - Finance &
Administration and Chief Financial Officer